PT  - JOURNAL ARTICLE
AU  - Harika Keerthi
AU  - Pavan Kumar Panakanti
AU  - Madhusudan Rao Yamsani
TI  - Design and Characterization of Atenolol Transdermal Therapeutic Systems: Enhancement of Permeability via Iontophoresis
AID  - 10.5731/pdajpst.2012.00872
DP  - 2012 Jul 01
TA  - PDA Journal of Pharmaceutical Science and Technology
PG  - 318--332
VI  - 66
IP  - 4
4099  - http://journal.pda.org/content/66/4/318.short
4100  - http://journal.pda.org/content/66/4/318.full
SO  - PDA J Pharm Sci Technol2012 Jul 01; 66
AB  - The aim of the present investigation was to improve the permeation of Atenolol by preparing a transdermal patch and using the method of iontophoresis. Influence of chemical penetration enhancers was also studied. Combination of iontophoresis and chemical penetration enhancer d-limonene and oleic acid produced satisfactory permeation and flux. The electrically driven penetration enhancement provided by this method has succeeded in overcoming the formidable barrier presented by the stratum corneum, and has shown to be a promising technique for the transport of hydrophilic drug Atenolol from polymeric films. Atenolol is a water-soluble, ionizable drug and suffers from poor bioavailability when given by oral route due to its incomplete intestinal absorption and first-pass metabolism. Being a BCS class III drug, Atenolol has low log P (0.23) value, which also may be the reason for its poor intestinal absorption. Iontophoretic delivery using Ag/AgCl electrodes with current density of 0.35 mA/cm2 enhances its delivery rate and thereby overcomes the problem of incomplete absorption. The prepared transdermal patches were subjected to ex vivo drug permeation studies using rat skin in phosphate buffer pH 7.4 for 24 h (passive and iontophoresis), and samples collected were analyzed by gradient high-pressure liquid chromatography. The column used was chiral alpha-glycoprotein (AGP) column (10 cm, particle size 5μ) and UV-detection at 225 nm was used. The effectiveness of permeation enhancers (d-Limonene and oleic acid) was determined by comparing drug flux in the presence and absence of each enhancer. Combination strategies of iontophoresis with chemical enhancers like oleic acid led to the significantly higher flux levels compared with passive transdermal delivery.